|
TOPORS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.01481103707147E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.99119651059732E-11 |
| Normal-vs-Stage2 |
1.27879999922698E-08 |
| Normal-vs-Stage3 |
2.57505128331559E-12 |
| Normal-vs-Stage4 |
2.40918396343659E-14 |
| Stage1-vs-Stage2 |
7.158800E-01 |
| Stage1-vs-Stage3 |
3.931500E-02 |
| Stage1-vs-Stage4 |
7.201800E-04 |
| Stage2-vs-Stage3 |
3.202000E-01 |
| Stage2-vs-Stage4 |
6.772400E-02 |
| Stage3-vs-Stage4 |
2.306800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.22224494151169E-12 |
| Normal-vs-AfricanAmerican |
3.7763000000024E-05 |
| Normal-vs-Asian |
1.45490000047488E-08 |
| Caucasian-vs-AfricanAmerican |
3.561000E-01 |
| Caucasian-vs-Asian |
2.750600E-01 |
| AfricanAmerican-vs-Asian |
9.233000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22930571172719E-12 |
| Normal-vs-Female |
1.70780056762965E-11 |
| Male-vs-Female |
2.178400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.93349846822866E-11 |
| Normal-vs-Age(41-60Yrs) |
1.05839781383565E-11 |
| Normal-vs-Age(61-80Yrs) |
5.43121103646627E-13 |
| Normal-vs-Age(81-100Yrs) |
2.968600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.160000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.553500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.781200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.928440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.491000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.987200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.369770E-02 |
| Classical-VS-Follicular |
3.198400E-02 |
| Classical-VS-Other |
4.464200E-01 |
| Classical-VS-Normal |
8.07919953160763E-10 |
| Tall-VS-Follicular |
5.842800E-01 |
| Tall-VS-Other |
7.763000E-01 |
| Tall-VS-Normal |
1.60129687287736E-11 |
| Follicular-VS-Other |
9.820600E-01 |
| Follicular-VS-Normal |
2.18924878225835E-12 |
| Other-VS-Normal |
1.622750E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.07870395843679E-11 |
| N0-vs-N1 |
5.239000E-01 |
|
|
